Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term real-world data of ustekinumab in Crohn's disease: the Stockholm ustekinumab study.
Bello F, Muhsen S, Sabhan H, Borin A, Johansson F, Höög C, Forsberg O, Wennerström C, Söderman C, Lördal M, Almer S. Bello F, et al. Among authors: wennerstrom c. Therap Adv Gastroenterol. 2024 Apr 23;17:17562848241242700. doi: 10.1177/17562848241242700. eCollection 2024. Therap Adv Gastroenterol. 2024. PMID: 38655034 Free PMC article.
Objectively assessed disease activity and drug persistence during ustekinumab treatment in a nationwide real-world Crohn's disease cohort.
Af Björkesten CG, Ilus T, Hallinen T, Soini E, Eberl A, Hakala K, Heikura M, Jussila A, Koskela R, Koskinen I, Moilanen V, Nielsen C, Nieminen U, Nuutinen H, Heikkinen M, Suhonen UM, Tillonen J, Utriainen K, Vihriälä I, Wennerström C, Borsi A, Nissinen R, Koivunen MR, Sipponen T. Af Björkesten CG, et al. Among authors: wennerstrom c. Eur J Gastroenterol Hepatol. 2020 Dec;32(12):1507-1513. doi: 10.1097/MEG.0000000000001831. Eur J Gastroenterol Hepatol. 2020. PMID: 32868649 Free PMC article.
Ustekinumab for Crohn's disease: a nationwide real-life cohort study from Finland (FINUSTE).
Eberl A, Hallinen T, Af Björkesten CG, Heikkinen M, Hirsi E, Kellokumpu M, Koskinen I, Moilanen V, Nielsen C, Nuutinen H, Suhonen UM, Utriainen K, Vihriälä I, Soini E, Wennerström C, Nissinen R, Borsi A, Koivunen M, Tillonen J, Sipponen T. Eberl A, et al. Among authors: wennerstrom c. Scand J Gastroenterol. 2019 Jun;54(6):718-725. doi: 10.1080/00365521.2019.1624817. Epub 2019 Jun 11. Scand J Gastroenterol. 2019. PMID: 31184512
Societal costs attributable to Crohn's disease and ulcerative colitis within the first 5 years after diagnosis: a Danish nationwide cost-of-illness study 2002-2016.
Vadstrup K, Alulis S, Borsi A, Elkjaer Stallknecht S, Nielsen A, Rikke Jørgensen T, Wennerström C, Qvist N, Munkholm P. Vadstrup K, et al. Among authors: wennerstrom c. Scand J Gastroenterol. 2020 Jan;55(1):41-46. doi: 10.1080/00365521.2019.1707276. Epub 2020 Jan 21. Scand J Gastroenterol. 2020. PMID: 31960726
Persistence of advanced systemic pharmacological treatment of moderate-to-severe psoriasis among bio-naïve patients-A retrospective register-based cohort study in Finland and Sweden.
Tskhvarashvili G, Aher K, Sveide I, Katus U, Westerlund A, Hoti F, Wennerström C, Hassan F, Lee J, Hermanrud C, Johnsson I, Passey A, Nissinen R, Polesie S, Mälkönen T, Saarelainen L. Tskhvarashvili G, et al. Among authors: wennerstrom c. J Eur Acad Dermatol Venereol. 2024 Aug 2. doi: 10.1111/jdv.20198. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39092632
WBRT vs. APBI: an interim report of patient satisfaction and outcomes.
Bitter SM, Heffron-Cartwright P, Wennerstrom C, Weatherford J, Einstein D, Keiler LC. Bitter SM, et al. Among authors: wennerstrom c. J Contemp Brachytherapy. 2016 Feb;8(1):17-22. doi: 10.5114/jcb.2016.57816. Epub 2016 Feb 9. J Contemp Brachytherapy. 2016. PMID: 26985193 Free PMC article.